The FDA has approved three HIV products since June 2025, and the late-stage pipeline is testing how far apart doses can be spaced. Here are the milestones payers and health systems should track through 2027.
Feature|Videos|May 2, 2025
High Costs of Specialty Pharmacy Make SDOH, Health Literacy Especially Relevant, Says Tiara Green, M.S.Ed. | Asembia's AXS25 Summit
Author(s)Peter Wehrwein, Managing Editor
High costs and the novelty and complexity of new therapies such as gene therapy present social determinants of health and health literacy challenges, says Tiara Green, president of Accessia Health
Advertisement
In this segment of an interview with Managed Healthcare Executive, Tiara Green, M.S. Ed., president of Accessia Health, said the high cost of specialty pharmacy drugs makes social determinants of health especially relevant. "When we think about social determinants of health, we are talking about those factors that are going to impede individuals from accessing their healthcare." Green cited transportation as one such factor. She also spoke about the challenges posed by high-cost gene therapies. Will people have access to even know about these therapies, she asked rhetorically. "How do we ensure that individuals take care into their own hands to do the research or even know how to do the research to make informed healthcare decisions in partnership with their physicians?"
Advertisement
Related to this article
Hiva Pourarsalan at AMCP Nexus explains how MFP shifts Medicare drug pricing, disrupting rebates and contracting and forcing payers to rethink formularies.
EHRs miss many cancer deaths. Linking electronic health records with claims and third‑party death data sharply improves accuracy, Tempus reports at AMCP Nexus.
CMS projects roughly 2.3 million people will lose Medicaid coverage in 2027 under the new community engagement requirements, also referred to as work requirements: four in ten to paperwork, not noncompliance. Arkansas showed how that happens; here is what plans can learn before the clock starts.
Managed care leaders should vet AI tools before use and recheck them over time, and pharmacists need AI literacy, according to two AMCP Nexus 2026 presenters.
AI is speeding up managed care pharmacy work, but two pharmacists say human review remains key when tools affect patients' access to medications.
A review of 16 studies linked presurgical melatonin and zolpidem to less postoperative pain, with over 30% less opioid use in some patients.
Prime Therapeutics' Pat Gleason, Pharm.D., outlined T1D screening gaps for plans and his priorities as incoming AMCP president.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
5 things you should know about the midterms and healthcare
2
Prime's Pat Gleason flags cost, timing gaps in type 1 diabetes screening | AMCP Nexus 2026
3
5 things you should know about intismeran, the Moderna-Merck cancer vaccine
4
Narcolepsy type 1 drives 5-fold higher costs in first year after diagnosis
5